What CDSCO's New SEC Guidelines Mean for Pharma and Medical Device Companies
The Central Drugs Standard Control Organisation (CDSCO) has issued its first formal guidelines on Subject Expert Committees (SECs) for drug, biologic, and medical device approvals. Rishi Agrawal, Co-Founder and CEO of TeamLease RegTech, shares insights on how these changes will impact pharmaceutical and medical device companies.
Drugs Controller General Of India (DCGI) | 02/09/2025
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy